Table 2.
Perioperative and postoperative characteristics of patients with Karnofsky Performance Scale score (KPS) ≤60 who underwent surgery for an intracranial glioblastoma (GB)
| Characteristics | Number (%) |
|---|---|
| Surgical variables | |
| Radical resection (>95%) | 55 (55%) |
| Subtotal resection (<95%) | 45 (45%) |
| Perioperative | |
| Mortality | 0 (0%) |
| New motor deficit | 10 (10%) |
| New language deficit | 0 (0%) |
| New visual deficit | 3 (3%) |
| Hospital stay (days)* | 6 (5–10) |
| Adjuvant therapy | |
| Carmustine wafers | 23 (23%) |
| Temozolomide | 22 (22%) |
| Radiation therapy | 78 (78%) |
| Survival | |
| Died at last follow-up | 88 (88%) |
| Median survival (months) | 6.6 |
| 3-month survival rate | 73% |
| 6-month survival rate | 52% |
| 9-month survival rate | 41% |
| 12-month survival rate | 32% |
| 18-month survival rate | 14% |
| 24-month survival rate | 8% |
*
Median (interquartile range).